SCHEMBL22928101

SCHEMBL22928101

CC(C)(c1ccc2c(c1)NC(=O)C2=O)C(C)(C)c1cccc2c1C(=O)C(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 7/20 0.41
MAOB P27338 7/20 0.41
CES1 P23141 5/20 0.41
TGM2 P21980 1/20 0.40
BCHE P06276 1/20 0.33
PDPK1 O15530 1/20 0.33
ROCK2 O75116 1/20 0.33
FES P07332 1/20 0.33
FER P16591 1/20 0.33
MARK3 P27448 1/20 0.33
FLT3 P36888 1/20 0.33
MAP4K2 Q12851 1/20 0.33
PKN2 Q16513 1/20 0.33
CDC42BPA Q5VT25 1/20 0.33
SLK Q9H2G2 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
ALDH1A1 P00352 2/20 0.33
ROS1 P08922 1/20 0.33
CDK5 Q00535 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928678 0.75 CES1 (0.55) MAOAMAOBCES1TGM2PDPK1
SCHEMBL28878753 0.69 CES1 (0.55) MAOAMAOBCES1TGM2
SCHEMBL6179037 0.69 CES1 (0.55) MAOAMAOBCES1SLKPOLB
SCHEMBL4679100 0.69 CES1 (0.55) MAOAMAOBCES1TGM2
Toluene SCHEMBL28094131 0.66 MAOA (0.51) MAOAMAOBCES1TGM2BCHE
SCHEMBL30398896 0.64 CES1 (0.62) MAOAMAOBCES1TGM2BCHE
SCHEMBL4192180 0.64 CES1 (0.62) MAOAMAOBCES1TGM2BCHE
SCHEMBL18955266 0.64 CES1 (0.45) MAOAMAOBCES1TGM2ROCK2
SCHEMBL2136384 0.63 CES1 (0.60) MAOAMAOBCES1PDPK1FLT3
SCHEMBL1247409 0.62 TGM2 (0.55) MAOAMAOBCES1TGM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF MEDICONNS SHANGHAI BIOPHARMACEUTICAL CO LTD (CN) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024498-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF PRLHR, DRD2, AVPR2 MAOA 1717/4885MAOB 1412/4885CES1 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.